Cancer immunotherapy - Converting immune failure to clinical response

被引：0
|
作者：
Olweus, Johanna [1 ]
机构：
[1] Oslo Univ Hosp Radiumhosp, Dept Canc Immunol, Inst Canc Res, Ullernchausseen 70, N-0310 Oslo, Norway
来源：
MOLECULAR ONCOLOGY | 2015年 / 9卷 / 10期
关键词：
VACCINES;
D O I：
10.1016/j.molonc.2015.10.017
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1891 / 1893
页数：3
相关论文
共 50 条
  • [41] Antitumor and Adjuvant Activity of λ-carrageenan by Stimulating Immune Response in Cancer Immunotherapy
    Min Luo
    Bin Shao
    Wen Nie
    Xia-Wei Wei
    Yu-Li Li
    Bi-Lan Wang
    Zhi-Yao He
    Xiao Liang
    Ting-Hong Ye
    Yu-Quan Wei
    Scientific Reports, 5
  • [42] The Immune Response to Esophageal Cancer Surgery: Implications for Postoperative Adjuvant Immunotherapy
    Donlon, N. E.
    Davern, M.
    Sheppard, A.
    O'Connell, F.
    Temperley, H.
    McClean, M.
    Ravi, N.
    Donohoe, C.
    Reynolds, J. V.
    Lysaght, J.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2021, 190 (SUPPL 6) : S244 - S245
  • [43] Dendritic cells as natural adjuvants and modulators of immune response in cancer immunotherapy
    Alli, RS
    Khar, A
    INDIAN JOURNAL OF BIOCHEMISTRY & BIOPHYSICS, 2002, 39 (06): : 363 - 367
  • [44] Assessment of cancer immunotherapy outcome in terms of the immune response time features
    Rodríguez-Pérez, D.
    Sotolongo-Grau, Oscar
    Riquelme, Ramón Espinosa
    Sotolongo-Costa, Oscar
    Antonio Santos Miranda, J.
    Antoranz, J.C.
    Mathematical Medicine and Biology, 2008, 25 (01) : 287 - 300
  • [45] Immune subtyping for pancreatic cancer with implication in clinical outcomes and improving immunotherapy
    Jingkai Liu
    Qiaofei Liu
    Xiang Zhang
    Ming Cui
    Tong Li
    Yalu Zhang
    Quan Liao
    Cancer Cell International, 21
  • [46] Immune subtyping for pancreatic cancer with implication in clinical outcomes and improving immunotherapy
    Liu, Jingkai
    Liu, Qiaofei
    Zhang, Xiang
    Cui, Ming
    Li, Tong
    Zhang, Yalu
    Liao, Quan
    CANCER CELL INTERNATIONAL, 2021, 21 (01)
  • [47] Immune Aging and Immunotherapy in Cancer
    Kaiser, Melanie
    Semeraro, Maria Donatella
    Herrmann, Markus
    Absenger, Gudrun
    Gerger, Armin
    Renner, Wilfried
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (13)
  • [48] IMMUNE RNA IN IMMUNOTHERAPY OF CANCER
    PILCH, YH
    FRITZE, D
    KERN, DH
    MEDICAL CLINICS OF NORTH AMERICA, 1976, 60 (03) : 567 - 583
  • [49] Immune monitoring in cancer immunotherapy
    Romero, P
    Pillet, MJ
    Valmori, D
    Speiser, DE
    Cerundolo, V
    Liénard, D
    Lejeune, F
    Cerottini, JC
    THERAPEUTIC VACCINATION STRATEGIES, 2000, 30 : 75 - 97
  • [50] HUMORAL IMMUNE-RESPONSE TO INTRALYMPHATIC IMMUNOTHERAPY FOR DISSEMINATED MELANOMA - CORRELATION WITH CLINICAL-RESPONSE
    AHN, SS
    IRIE, RF
    WEISENBURGER, TH
    JONES, PC
    JUILLARD, G
    ROE, DJ
    MORTON, DL
    SURGERY, 1982, 92 (02) : 362 - 367
12345